Regulatory press release12/16/2025, 7:57 AMChordate Medical säger upp likviditetsgarantin för stamaktien
Regulatory press release12/16/2025, 7:57 AMChordate Medical terminates the liquidity guarantee for the common share
Regulatory press release12/8/2025, 3:30 PMKommuniké från extra bolagsstämma i Chordate Medical Holding AB (publ)
Regulatory press release12/8/2025, 3:30 PMBulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Regulatory press release11/18/2025, 6:40 PMKallelse till extra bolagsstämma i Chordate Medical Holding AB (publ)
Regulatory press release11/18/2025, 6:40 PMNotice to the Extraordinary General Meeting in Chordate Medical Holding AB (publ)
Regulatory press release11/18/2025, 6:30 PMStyrelsen för Chordate föreslår att bolagsstämman fattar beslut om frivillig likvidation och avnotering
Regulatory press release11/18/2025, 6:30 PMThe board of directors of Chordate proposes that the general meeting resolves on voluntary liquidation and delisting
Regulatory press release8/29/2025, 6:30 AMChordate Medical Holding AB (publ) Delårsrapport januari-juni 2025
Regulatory press release8/21/2025, 6:30 AMChordate meddelar kostnadsreduktion och fokusering på bolagsförsäljning
Regulatory press release8/21/2025, 6:30 AMChordate Announces Cost Reduction and Focus on Company Sale
Press release8/19/2025, 6:30 AMChordate redovisar preliminära slutsatser från långtidsstudien om kronisk migrän: PM010
Press release8/19/2025, 6:30 AMChordate reports preliminary conclusions from long-term study on chronic migraine: PM010